Painreform Ltd (PRFX)

02:25 AM

PainReform (NASDAQ:PRFX) vs. Citius Pharmaceuticals (NASDAQ:CTXR) Financial Comparison - Defense World

02:25 AM

Jan 09, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Jan 09, 2026

Jan 08, 2026

What analyst consensus says on PainReform Ltd. stockJuly 2025 Levels & Free Weekly Watchlist of Top Performers - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Is PainReform Ltd. stock attractive after correctionPortfolio Risk Report & Pattern Based Trade Signal System - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

PainReform Ltd. (PRFX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 08, 2026

Jan 07, 2026

PainReform Files Pro Forma Financials Following Majority Acquisition of LayerBio - TipRanks

Jan 07, 2026

Jan 06, 2026

Can PainReform Ltd. stock deliver sustainable ROE2026 world cup usa national team third place match playmakers possession football match prediction preview - ulpravda.ru

Jan 06, 2026

Jan 06, 2026

PainReform Shareholders Approve All Proposals at Adjourned 2026 Annual Meeting - TipRanks

Jan 06, 2026

Jan 05, 2026

PainReform Ltd's Deepsolar Launches Smart TDD, A Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market - MarketScreener

Jan 05, 2026

Jan 05, 2026

PainReform (PRFX) Introduces Advanced Solar Audit Service with S - GuruFocus

Jan 05, 2026

Jan 05, 2026

PainReform’s DeepSolar Unveils Smart TDD to Speed and Sharpen Solar Asset Due Diligence - TipRanks

Jan 05, 2026

Jan 05, 2026

PainReform Ltd. Launches Smart TDD: Advanced Solar Technical Due Diligence Service to Enhance Asset Performance and Risk Assessment - Quiver Quantitative

Jan 05, 2026

Jan 05, 2026

PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market - Yahoo Finance

Jan 05, 2026

Dec 30, 2025

PainReform Adjourns Annual Shareholder Meeting Due to Lack of Quorum - TipRanks

Dec 30, 2025

Dec 30, 2025

AI drones join $600B push to keep UAE and Middle East solar farms efficient - Stock Titan

Dec 30, 2025

Dec 23, 2025

Is PainReform Ltd stock attractive after correctionWeekly Stock Summary & Weekly Watchlist for Hot Stocks - moha.gov.vn

Dec 23, 2025

Dec 20, 2025

Why PainReform Ltd. stock remains on buy listsTrade Risk Summary & Daily Oversold Stock Bounce Ideas - Улправда

Dec 20, 2025

Dec 19, 2025

Can PainReform Ltd. stock surprise with earnings upside2025 Price Action Summary & Growth Focused Entry Reports - Улправда

Dec 19, 2025

Dec 19, 2025

Published on: 2025-12-19 20:32:49 - Улправда

Dec 19, 2025

Dec 19, 2025

Published on: 2025-12-19 20:05:02 - Улправда

Dec 19, 2025

Dec 19, 2025

Is PainReform Ltd. stock overvalued by current metricsWeekly Trend Recap & Daily Volume Surge Signals - Улправда

Dec 19, 2025

Dec 19, 2025

What hedge fund activity signals for PainReform Ltd. stockPrice Action & Long-Term Investment Growth Plans - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How risky is PainReform Ltd. stock nowWall Street Watch & Long-Term Safe Investment Ideas - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is PainReform Ltd. stock attractive for income investorsWeekly Stock Summary & AI Powered Market Trend Analysis - Улправда

Dec 19, 2025

Dec 14, 2025

What drives PainReform Ltd stock priceTop Performing Stocks & Download Our Free Trading Blueprint - earlytimes.in

Dec 14, 2025

Dec 13, 2025

PainReform completed R&D assessment of LayerBio’s drug-delivery platform - MSN

Dec 13, 2025

Dec 12, 2025

Published on: 2025-12-13 11:33:01 - moha.gov.vn

Dec 12, 2025

Dec 11, 2025

Trend Recap: How PainReform Ltd stock performs after earningsQuarterly Investment Review & Proven Capital Preservation Methods - moha.gov.vn

Dec 11, 2025

Dec 10, 2025

PainReform’s LayerBio Platform Advances with Multi-Drug Capability - TipRanks

Dec 10, 2025

Dec 10, 2025

PainReform Ltd. Completes R&D Assessment of LayerBio's Sustained-Release Ocular Drug-Delivery Platform - Quiver Quantitative

Dec 10, 2025

Dec 10, 2025

PainReform (Nasdaq: PRFX) validates LayerBio drop-less ocular platform for multi-drug cataract care - Stock Titan

Dec 10, 2025

Dec 10, 2025

PainReform’s LayerBio platform advances with multi-drug capability - MSN

Dec 10, 2025

Dec 09, 2025

PainReform commences development plan for OcuRing-K Phase II trial - MSN

Dec 09, 2025

Dec 08, 2025

Is PainReform Ltd (PRFX) positioned for future growth? - Setenews

Dec 08, 2025

Dec 04, 2025

Will PainReform Ltd. stock pay special dividendsPortfolio Profit Report & Growth Oriented Trade Recommendations - Newser

Dec 04, 2025

Dec 04, 2025

Will PainReform Ltd. stock maintain dividend yieldMarket Volume Summary & Stock Portfolio Risk Management - Newser

Dec 04, 2025

Dec 02, 2025

PainReform Ltd. Commences Development for OcuRing??-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy - marketscreener.com

Dec 02, 2025

Dec 02, 2025

PainReform begins development plan for drop-less cataract surgery therapy By Investing.com - Investing.com

Dec 02, 2025

Dec 02, 2025

PainReform (PRFX) Advances OcuRing-K Development for Improved Ca - GuruFocus

Dec 02, 2025

Dec 02, 2025

PainReform Initiates Phase II Development for OcuRing™-K - TipRanks

Dec 02, 2025

Dec 02, 2025

Painreform commences development for Ocuring-K phase II trial - marketscreener.com

Dec 02, 2025

Dec 02, 2025

PainReform begins development plan for drop-less cataract surgery therapy - Investing.com

Dec 02, 2025

Dec 02, 2025

PainReform Commences Development for OcuRing™-K Phase II - GlobeNewswire

Dec 02, 2025

Dec 02, 2025

PainReform (Nasdaq: PRFX) moves OcuRing-K into Phase II plan in $9B cataract market - Stock Titan

Dec 02, 2025

Dec 01, 2025

PainReform Ltd. (PRFX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Dec 01, 2025

Nov 28, 2025

PainReform’s DeepSolar Advances with NVIDIA Connect and Pilot Projects - MSN

Nov 28, 2025